- Home
- PANL vs ATAI Comparison
PANL vs ATAI Comparison
Compare PANL & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- ATAI
- Stock Information
- Founded
- PANL 1996
- ATAI 2018
- Country
- PANL United States
- ATAI Germany
- Employees
- PANL N/A
- ATAI N/A
- Industry
- PANL Marine Transportation
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- PANL Consumer Discretionary
- ATAI Health Care
- Exchange
- PANL Nasdaq
- ATAI Nasdaq
- Market Cap
- PANL 357.3M
- ATAI 293.5M
- IPO Year
- PANL N/A
- ATAI 2021
- Fundamental
- Price
- PANL $4.36
- ATAI $1.32
- Analyst Decision
- PANL Strong Buy
- ATAI Strong Buy
- Analyst Count
- PANL 1
- ATAI 4
- Target Price
- PANL N/A
- ATAI $9.00
- AVG Volume (30 Days)
- PANL 274.6K
- ATAI 1.8M
- Earning Date
- PANL 03-13-2025
- ATAI 05-14-2025
- Dividend Yield
- PANL 9.15%
- ATAI N/A
- EPS Growth
- PANL 8.62
- ATAI N/A
- EPS
- PANL 0.63
- ATAI N/A
- Revenue
- PANL $536,536,246.00
- ATAI $308,000.00
- Revenue This Year
- PANL $13.67
- ATAI $65.58
- Revenue Next Year
- PANL $6.04
- ATAI N/A
- P/E Ratio
- PANL $6.94
- ATAI N/A
- Revenue Growth
- PANL 7.46
- ATAI N/A
- 52 Week Low
- PANL $4.35
- ATAI $1.03
- 52 Week High
- PANL $8.32
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- PANL 29.78
- ATAI 42.48
- Support Level
- PANL $4.67
- ATAI $1.22
- Resistance Level
- PANL $4.89
- ATAI $1.48
- Average True Range (ATR)
- PANL 0.18
- ATAI 0.12
- MACD
- PANL -0.07
- ATAI 0.00
- Stochastic Oscillator
- PANL 0.74
- ATAI 21.59
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.